Best Healthcare Companies in Central District, Israel
The 44 best Healthcare companies in Central District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Pharma Two B.
Ranked: Best Healthcare companies in Central District
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharma Two B Pharma Two B is a late-stage pharmaceutical company developing innovative combination products of previously… | $38M | 113 mo ago | Series C | — | 2007 | — | 75 patents Pharmaceutical formulations and active agents for Parkinson’s and neurodegenerative disease treatment | — |
| 2 | Can-Fite Developer of small molecules for autoimmune-inflammatory and cancer diseases | $26M | 56 mo ago | Public | Pnina Fishman Co-Founder & CEO | 1994 | BootstrapApache HTTP ServerLazySizes+17 | 264 patents A3 adenosine receptor agonist/ligand therapeutics for inflammation, cancer, and metabolic disorders | — |
| 3 | Procognia Contract research services for glycosylation and protein function studies | $24M | 261 mo ago | Public | Nir Peleg Ceo | 2000 | — | 14 patents Glycan and carbohydrate polymer analysis for disease diagnostics via saccharide binding | — |
| 4 | Proteologics Ubiquitin system-based drugs for cancer & infectious diseases | $17M | 297 mo ago | Acquired | — | 1999 | — | 49 patents Small-molecule inhibitors and synthetic ubiquitin tools for modulating ubiquitin ligases and inflammation | — |
| 5 | Quantomix Provider of electron & ion detection services for research, medical, and industrial applications | $12M | 264 mo ago | Acquired | Zachi Berger Co-Founder | 2000 | — | 9 patents Analytical instruments for SEM fluid sample inspection and metabolic disease diagnostics | — |
| 6 | Picodya Manufacturer of POC IVD | $10M | 72 mo ago | Series A | Eli Simon Co-Founder & Chairman | 2017 | — | — | — |
| 7 | Dynamix Pharmaceuticals Developing small molecule kinase II inhibitors for cancer and autoimmune diseases | $10M | 210 mo ago | Series A | Oren Becker Founder | 2009 | — | 9 patents Patents concentrated in chemistry & materials | — |
| 8 | Sequentify Provider of library-prep solutions for next-generation sequencing | $7M | 51 mo ago | Series A | — | 2021 | — | 3 patents Targeted DNA sequencing using embedded molecular inversion probe technologies | — |
| 9 | GemmaCert Provider of an analytical device for the verification of the potency of cannabis flowers | $3M | 102 mo ago | Series A | Dana Yarden Co-Founder | 2015 | — | 14 patents Analytical testing of plant material potency using spectroscopic/chemical analysis methods. | — |
Top 12 Healthcare companies in Central District
#1
Public · Petah Tikva, Central District · founded 1994 · 8 employees$25.5Mraised▾
Developer of small molecules for autoimmune-inflammatory and cancer diseases
#2
Series A · Rehovot, Central District · founded 2021 · 16 employees$7Mraised▾
Operator of a biotechnology company intended to offer novel library-preparation alternatives for genome sequencing. The company combines synthetic biology and artificial intelligence software tools to enable rapid targeted DNA sequencing at a reduced cost, enabling researchers to do genomic diagnostics and therapeutics at a population-wide scale.
- May 2022Series A$7M
#3
Series C · Rehovot, Central District · founded 2007 · 12 employees$38Mraised▾
Pharma Two B is a late-stage pharmaceutical company focused on developing innovative combination products of previously approved drugs to improve patient outcomes. The company is pioneering a novel approach to treating Parkinson's disease, with its lead product, P2B001, demonstrating promising results in clinical trials. With a strong pipeline of products in development, Pharma Two B is poised to make a significant impact in the pharmaceutical industry.
#4
Series A · Rehovot, Central District · founded 2017 · 29 employees$10Mraised▾
Manufacturer of POC IVD
- Aug 2020Series A$10M
#5
Public · Rehovot, Central District · founded 2000$23.8Mraised▾
Procognia, formerly known as Glycodata, provided contract research services for glycosylation and protein function studies. Its platform technology was a protein microarray that enabled analysis of protein glycosylation. Applications included drug discovery and development for biopharmaceutical companies. The company had an ongoing partnership with Teva, and in Jan 2003, acquired Sense Proteomic to expand its service portfolio. The company is deadpooled.
#6
Acquired · Rehovot, Central District · founded 1999$17Mraised▾
Ubiquitin system-based drugs for cancer & infectious diseases
#7
Acquired · Rehovot, Central District · founded 2000 · 17 employees$12.5Mraised▾
Provider of electron and ion detection services for research, medical and industrial applications. The company offers capsules for imaging of fully-hydrated samples with scanning electron microscopes (SEM); imaging of various wet materials and biological samples, such as food, cosmetics, oils, paints, particles in solutions, adherent and non-adherent cell and microorganisms; in-situ imaging of dynamic hydration processes; in-situ SEM imaging of various dynamic hydration processes and imaging of various solid and hydrated samples, such as tissue biopsies, plants and material specimens in their natural wet state.
#8
Series A · Rehovot, Central District · founded 2009 · 11 employees$10Mraised▾
Developer of novel, targeted, small-molecule drugs created to treat cancer and autoimmune disorders. The company's small-molecule drugs intervene with the metabolism of cancer cells and selectively target specific cellular signaling pathways, also known as Type II kinase inhibitors, enabling physicians to treat urgent and unmet medical needs in cancer and autoimmune disorders.
#9
Series A · Ra'anana, Central District · founded 2015 · 22 employees$3.2Mraised▾
GemmaCert provides an analytical device for the verification of the potency of cannabis flowers. Their proprietary technology combines optics and imaging analysis to overcome the challenges of the heterogeneous cannabis flower. It requires no solvents or grinding of the flower, thereby analyzing them without causing any damage. The device is meant for growers, processors, distributors, and dispensaries.
- Feb 2018Series A$2.2M
- Jan 2017Seed$1M
#10
Acquired · Rehovot, Central District · founded 2021—raised▾
Company that specializes in liquid biopsy. They have developed a mass-spectrometry serum test for identifying liver fibrosis and other diseases. Their unique approach combines population-scale serum samples with AI and analytical chemistry expertise to optimize patient care.
#11
Seed · Rishon Lezion, Central District · founded 2020—raised▾
Retailer of solutions and products for the elderly intending to change their life through professional service and the quality of the products. The company provides sports and physiotherapy products, pharmaceutical and cosmetic products, nutrition and supplements, medical equipment and so more.
- Dec 2022Seed—
#12
Seed · Netanya, Central District · founded 2014 · 7 employees—raised▾
Developer of smart plastic sensors intended to offer a fully integrated multi-sensing system on a plastic chip (SoPC) for direct integration into plastic products. The company's technology is designed to allow easy integration of the many small, wireless, battery-free, low-cost, with performance sensors to improve sensor fusion systems used for sensing, analytics, and insights, providing clients with reliable and cost-effective sensors needed in IoT and edge systems.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.